Ligand validation:3EJE

HTG: heptyl 1-thio-beta-D-glucopyranoside

HTG is a Ligand Of Interest in 3EJE designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3EJE_HTG_C_100	40%	74%	0.153	0.929	0.31	0.69	-	-	0	0	63%	0.6316
3EJE_HTG_E_100	31%	17%	0.173	0.886	2.27	1.37	2	1	0	0	74%	0.7368
3EJE_HTG_H_417	25%	29%	0.196	0.956	1.63	1.23	1	1	1	0	32%	0.3158
3EJE_HTG_D_417	20%	29%	0.169	0.892	1.63	1.2	1	-	0	0	32%	0.3158
3EJE_HTG_A_100	17%	9%	0.226	0.84	3.34	1.2	2	1	0	0	79%	0.7895
3EJE_HTG_B_417	16%	32%	0.198	0.892	1.65	1.06	1	-	4	0	32%	0.3158
3EJE_HTG_G_100	16%	74%	0.188	0.82	0.3	0.71	-	-	0	0	63%	0.6316
3EJB_HTG_G_100	62%	6%	0.093	0.922	3.76	1.37	2	1	0	0	79%	0.7895
3EJD_HTG_A_100	42%	9%	0.154	0.912	3.37	1.11	2	1	0	0	79%	0.7895
5V2C_HTG_O_303	94%	33%	0.072	0.972	1.58	1.07	2	2	0	0	100%	1
3WU2_HTG_O_303	89%	40%	0.092	0.971	1.13	1.22	2	1	0	0	100%	1
8IR7_HTG_b_625	81%	37%	0.086	0.939	0.97	1.5	2	3	0	0	100%	1
8IR6_HTG_b_625	81%	35%	0.088	0.941	1.07	1.48	2	4	0	0	100%	1
8IRA_HTG_B_625	81%	46%	0.097	0.95	0.97	1.12	2	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.